DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydroxyzine (Hydroxyzine) - Foetal Growth Restriction - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Foetal Growth Restriction (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydroxyzine where reactions include foetal growth restriction. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydroxyzine side effects in female

Reported by a lawyer from United States on 2012-08-24

Patient: female

Reactions: Speech Disorder, Cleft LIP and Palate, Foetal Growth Restriction, Foetal Heart Rate Abnormal, Otitis Media Chronic, Gastrooesophageal Reflux Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Hydroxyzine
    Indication: Foetal Exposure During Pregnancy

Zoloft
    Indication: Foetal Exposure During Pregnancy

Trazodone Hydrochloride
    Indication: Foetal Exposure During Pregnancy

Ibuprofen
    Indication: Foetal Exposure During Pregnancy

Fentanyl
    Indication: Foetal Exposure During Pregnancy

Effexor
    Indication: Foetal Exposure During Pregnancy

Colace
    Indication: Foetal Exposure During Pregnancy

Bupivacaine HCL
    Indication: Foetal Exposure During Pregnancy

Ibuprofen

Terbutaline
    Indication: Foetal Exposure During Pregnancy

Oxytocin
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy

Mirtazapine
    Indication: Foetal Exposure During Pregnancy

Other drugs received by patient: Multi-Vitamins; Metformin HCL; Risedronate Sodium; Folic Acid; Ferrous Sulfate TAB



Possible Hydroxyzine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: female

Reactions: Cleft LIP and Palate, Foetal Growth Restriction, Speech Disorder, Otitis Media Chronic, Gastrooesophageal Reflux Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Hydroxyzine
    Indication: Foetal Exposure During Pregnancy

Zoloft
    Indication: Foetal Exposure During Pregnancy

Trazodone HCL
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy

Mirtazapine
    Indication: Foetal Exposure During Pregnancy

Other drugs received by patient: Risedronate Sodium; Folic Acid; Metformin HCL



Possible Hydroxyzine side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-20

Patient: 32 year old female

Reactions: Foetal Growth Restriction, Premature Baby, Live Birth, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Ranitidine

Ondansetron
    Indication: Hyperemesis Gravidarum

Pantoprazole

Metoclopramide
    Dosage: 1.8-3.2 mg/h
    Indication: Hyperemesis Gravidarum

Acetaminophen

Hydroxyzine

Omeprazole

Diphenhydramine HCL
    Indication: Hyperemesis Gravidarum



Possible Hydroxyzine side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-20

Patient: 32 year old female

Reactions: Foetal Growth Restriction, Premature Baby, Maternal Exposure During Pregnancy, Live Birth

Drug(s) suspected as cause:
Pantoprazole

Metoclopramide
    Dosage: 1.8-3.2 mg/h
    Indication: Hyperemesis Gravidarum

Ondansetron
    Indication: Hyperemesis Gravidarum

Diphenhydramine HCL
    Indication: Hyperemesis Gravidarum

Hydroxyzine

Omeprazole

Ranitidine

Acetaminophen



Possible Hydroxyzine side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-20

Patient: 32 year old female

Reactions: Foetal Growth Restriction, Premature Baby, Maternal Exposure During Pregnancy, Live Birth, NO Therapeutic Response, Premature Delivery

Drug(s) suspected as cause:
Pantoprazole

Ranitidine

Diphenhydramine HCL
    Indication: Hyperemesis Gravidarum

Omeprazole

Metoclopramide
    Dosage: 1.8-3.2 mg/h
    Indication: Hyperemesis Gravidarum

Ondansetron
    Indication: Hyperemesis Gravidarum

Acetaminophen

Hydroxyzine



Possible Hydroxyzine side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-20

Patient: 32 year old female

Reactions: Foetal Growth Restriction, Premature Baby, Live Birth, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Omeprazole

Ondansetron
    Indication: Hyperemesis Gravidarum

Hydroxyzine

Acetaminophen

Pantoprazole

Diphenhydramine HCL
    Indication: Hyperemesis Gravidarum

Ranitidine

Metoclopramide
    Dosage: 1.8-3.2 mg/h
    Indication: Hyperemesis Gravidarum



Possible Hydroxyzine side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-20

Patient: 32 year old female

Reactions: Foetal Growth Restriction, Premature Baby, Live Birth, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Hydroxyzine

Pantoprazole

Ranitidine

Acetaminophen

Ondansetron
    Indication: Hyperemesis Gravidarum

Omeprazole

Metoclopramide
    Dosage: 1.8-3.2 mg/h
    Indication: Hyperemesis Gravidarum

Diphenhydramine HCL
    Indication: Hyperemesis Gravidarum



Possible Hydroxyzine side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-20

Patient: 32 year old female

Reactions: Foetal Growth Restriction, Premature Baby, Maternal Exposure During Pregnancy, Live Birth

Drug(s) suspected as cause:
Ondansetron
    Indication: Hyperemesis Gravidarum

Pantoprazole

Ranitidine

Acetaminophen

Omeprazole

Hydroxyzine

Metoclopramide
    Dosage: 1.8-3.2 mg/h
    Indication: Hyperemesis Gravidarum

Diphenhydramine HCL
    Indication: Hyperemesis Gravidarum



Possible Hydroxyzine side effects in

Reported by a physician from Canada on 2012-04-05

Patient:

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Ranitidine

Pantoprazole

Omeprazole

Ondansetron
    Indication: Hyperemesis Gravidarum

Hydroxyzine
    Dosage: 25mg four times per day
    Indication: Hyperemesis Gravidarum

Thiamine HCL
    Indication: Hyperemesis Gravidarum

Metoclopramide
    Indication: Hyperemesis Gravidarum

Multi-Vitamins
    Indication: Hyperemesis Gravidarum

Diphenhydramine HCL
    Dosage: 50mg four times per day
    Indication: Hyperemesis Gravidarum

Acetaminophen



Possible Hydroxyzine side effects in

Reported by a physician from Canada on 2012-04-05

Patient:

Reactions: Foetal Growth Restriction, Hypoglycaemia Neonatal, Maternal Drugs Affecting Foetus, Foetal Exposure During Pregnancy, Hypoglycaemia

Drug(s) suspected as cause:
Pantoprazole

Ondansetron
    Indication: Hyperemesis Gravidarum

Oxazepam

Hydroxyzine
    Dosage: 25mg four times per day
    Indication: Hyperemesis Gravidarum

Diphenhydramine HCL
    Dosage: 50mg four times per day
    Indication: Hyperemesis Gravidarum

Metoclopramide
    Indication: Hyperemesis Gravidarum

Cosyntropin

Humulin R

Sumatriptan

Aspirin

Thiamine HCL
    Indication: Hyperemesis Gravidarum

Multi-Vitamins
    Indication: Hyperemesis Gravidarum

Hydromorphone HCL

Insulin Aspart



Possible Hydroxyzine side effects in

Reported by a physician from Canada on 2012-04-05

Patient:

Reactions: Foetal Growth Restriction, Foetal Exposure During Pregnancy, Hypoglycaemia

Drug(s) suspected as cause:
Oxazepam

Pantoprazole

Multi-Vitamins
    Indication: Hyperemesis Gravidarum

Hydroxyzine
    Dosage: 25mg four times per day
    Indication: Hyperemesis Gravidarum

Humulin R

Sumatriptan

Insulin Aspart

Ondansetron
    Indication: Hyperemesis Gravidarum

Aspirin

Diphenhydramine HCL
    Dosage: 50mg four times per day
    Indication: Hyperemesis Gravidarum

Metoclopramide
    Indication: Hyperemesis Gravidarum

Thiamine HCL
    Indication: Hyperemesis Gravidarum

Cosyntropin

Hydromorphone HCL

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017